Taiwanese Healthcare Global Supply Chain Shortage

Excelsior Medical

Market Cap: NT$14.5b

Sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, the Philippines, and Malaysia.

CHC Healthcare Group

Market Cap: NT$7.9b

Engages in trading of pharmaceutical products and health food in Taiwan, China, and internationally.

Hi-Clearance

Market Cap: NT$6.4b

Supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan.

WeLeader Biomedical

Market Cap: NT$2.7b

Operates as an agent and distributor of in vitro diagnostic products.

Arich Enterprise

Market Cap: NT$1.7b

Engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan.

Shangya Technology

Market Cap: NT$1.4b

Engages in the wholesale of Chinese medicines, western medicines, medical equipment, slimming products, and beauty products in Taiwan.

Cowealth Medical Holding

Market Cap: NT$1.4b

Engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong.

Excelsior Biopharma

Market Cap: NT$1.2b

Develops and sells pharmaceutical products in Taiwan, China, and internationally.

Level Biotechnology

Market Cap: NT$1.1b

Engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan.

UniPharma

Market Cap: NT$520.1m

Engages in the distribution of pharmaceutical drugs, medical devices, and diagnostic tests in Taiwan.